Early phase oncology research is often described as cutting edge. In practice, it is just as defined by logistics as by science. For Dr. Sankhala, the work of advancing new therapies has always been inseparable from a more practical question: how do patients outside large academic centers, who are often limited by cost, geography, or system barriers, gain timely access to clinical trials?